Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL8067893 | 1.00 | ALOX15 (0.52) | ALOX15ALDH1A1AKR1C3KMT2AMEN1 | |
| Benzoic Acid SCHEMBL23581094 | 0.85 | TSHR (0.52) | ALOX15KMT2AMEN1GAACYP3A4 | |
| Terephthalic Acid SCHEMBL6544696 | 0.81 | TP53 (0.48) | ALDH1A1CYP3A4CA12CA1CA2 | |
| Isophthalic Acid SCHEMBL6544630 | 0.79 | CA12 (0.44) | ALDH1A1KMT2AMEN1GAACYP2C9 | |
| Phthalic Acid SCHEMBL11485468 | 0.79 | ALOX15 (0.61) | ALOX15ALDH1A1KMT2AMEN1GAA | |
| SCHEMBL21891706 | 0.77 | ALDH1A1 (0.47) | ALOX15ALDH1A1AKR1C3KMT2AMEN1 | |
| Phthalic Acid SCHEMBL11171682 | 0.77 | ALDH1A1 (0.56) | ALOX15ALDH1A1AKR1C3CYP3A4CYP2D6 | |
| Acetic Acid SCHEMBL986871 | 0.75 | FFAR3 (0.38) | ALDH1A1KMT2AMEN1GAACYP2C19 | |
| Phthalic Acid SCHEMBL590260 | 0.75 | ALDH1A1 (0.74) | ALOX15ALDH1A1AKR1C3KMT2ACYP3A4 | |
| Phthalic Acid SCHEMBL2160580 | 0.75 | ALDH1A1 (0.82) | ALOX15ALDH1A1AKR1C3GAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040122270-A1 | In-situ polymerization of monoethylenically unsaturated monomers with secondary amines | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-24 | — | — | US | disclosed |
| EP-1428838-A1 | In situ-polymerization of monoethylenically unsaturated monomers with secondary amines | Bayer MaterialScience AG (DE) | 2004-06-16 | — | — | EP | disclosed |
| EP-1428839-A1 | In-situ polymerization of monoethylenically unsaturated monomers with secondary amines | Bayer MaterialScience AG (DE) | 2004-06-16 | — | — | EP | disclosed |
| US-6686424-B2 | USE IN RADICAL POLYMERIZATION; REACTING AN OXIDIZING AGENT WITH A STERICALLY HINDERED SECONDARY AMINE TO PRODUCE A NITROXY RADICAL; ADDING TO THE NITROXY RADICAL ONE OR MORE VINYL MONOMER | BAYER AKTIENGESELLSCHAFT (DE) | 2004-02-03 | — | — | US | disclosed |
| EP-1375476-A1 | A new process for the synthesis of alkoxyamines active in controlled radical polymerization | Bayer Aktiengesellschaft (DE) | 2004-01-02 | — | — | EP | disclosed |
| EP-1375457-A1 | One-pot process for the preparation of functionalized alkoxyamines | Bayer Aktiengesellschaft (DE) | 2004-01-02 | — | — | EP | disclosed |
| US-20040002606-A1 | Process for the synthesis for alkoxy amines and their use in controlled radical polymerization | BAYER AKTIENGESELLSCHAFT (DE) | 2004-01-01 | — | — | US | disclosed |
| US-20030236368-A1 | PREPARATION OF FUNCTIONALIZED ALKOXYAMINE INITIATOR AND ITS USE | BAYER AKTIENGESELLSCHAFT (DE) | 2003-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236368-A1 | PREPARATION OF FUNCTIONALIZED ALKOXYAMINE INITIATOR AND ITS USE | NOS1, NOS2, CBR1 | ALOX15 148/4885ALDH1A1 65/4885AKR1C3 84/4885 |
| US-20040002606-A1 | Process for the synthesis for alkoxy amines and their use in controlled radical polymerization | ALKBH3, MAOB, ALKBH1 | ALOX15 133/4885ALDH1A1 47/4885AKR1C3 32/4885 |
| US-20040122270-A1 | In-situ polymerization of monoethylenically unsaturated monomers with secondary amines | ALOX5, PARG, FASN | ALOX15 7/4885ALDH1A1 797/4885AKR1C3 870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.